Telix Pharmaceuticals Limited Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 196.74 K | $1.88 M | 100.00% | 0.06% |
| PORTLAND INVESTMENT COUNSEL INC. | 11/13/2025 | 128.00 K | $1.22 M | 100.00% | 0.04% |
| FMR LLC | 11/13/2025 | 118.48 K | $1.13 M | 181.48% | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 11/14/2025 | 114.62 K | $1.10 M | 100.00% | 0.03% |
| JANE STREET GROUP, LLC | 11/14/2025 | 72.99 K | $698.53 K | 107.94% | 0.02% |
| MARSHALL WACE, LLP | 11/13/2025 | 48.57 K | $464.84 K | 100.00% | 0.01% |
| PRIVATE ADVISOR GROUP, LLC | 11/13/2025 | 42.11 K | $403.02 K | 67.33% | 0.01% |
| IHT WEALTH MANAGEMENT, LLC | 11/14/2025 | 26.21 K | $250.82 K | 97.95% | 0.01% |
| JPMORGAN CHASE & CO | 11/26/2025 | 25.36 K | $242.65 K | 100.00% | 0.01% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 10/31/2025 | 18.38 K | $175.88 K | -0.53% | 0.01% |
| HRT FINANCIAL LP | 11/14/2025 | 11.64 K | $111.00 K | 100.00% | 0.00% |
| UBS GROUP AG | 11/13/2025 | 5.57 K | $53.26 K | -9.08% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 3.23 K | $30.95 K | -26.53% | 0.00% |
| RHUMBLINE ADVISERS | 11/06/2025 | 2.58 K | $24.68 K | 117.27% | 0.00% |
| NEWEDGE ADVISORS, LLC | 11/17/2025 | 2.40 K | $22.97 K | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 2.15 K | $20.58 K | 100.00% | 0.00% |
| STATE OF WYOMING | 11/04/2025 | 1.29 K | $12.37 K | 100.00% | 0.00% |
| RONALD BLUE TRUST, INC. | 10/16/2025 | 1.21 K | $11.54 K | 100.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 11/14/2025 | 1.03 K | $9.86 K | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 336 | $3.22 K | 646.67% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/10/2025 | 125 | $1.20 K | 86.57% | 0.00% |
| LARSON FINANCIAL GROUP LLC | 11/14/2025 | 53 | $507 | 100.00% | 0.00% |
| ASSETMARK, INC | 11/06/2025 | 41 | $392 | 127.78% | 0.00% |
| TRANSAMERICA FINANCIAL ADVISORS, INC. | 11/14/2025 | 25 | $239 | 100.00% | 0.00% |
| PRINCIPAL SECURITIES, INC. | 11/12/2025 | 21 | $201 | 0.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 10/14/2025 | 9 | $86 | 100.00% | 0.00% |
| TRUE WEALTH DESIGN, LLC | 10/21/2025 | 3 | $29 | -70.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BLAIR WILLIAM & CO/IL | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| PIER CAPITAL, LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| JFS WEALTH ADVISORS, LLC | 11/10/2025 | 0 | $0 | -100.00% | 0.00% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Telix Pharmaceuticals Limited institutional Ownership - FAQ's
During the previous two years, 34 institutional investors and hedge funds held shares of Telix Pharmaceuticals Limited. The most heavily invested institutionals were:
MILLENNIUM MANAGEMENT LLC: 196,741
PORTLAND INVESTMENT COUNSEL INC.: 128,000
FMR LLC: 118,479
LAZARD ASSET MANAGEMENT LLC: 114,624
JANE STREET GROUP, LLC: 72,992
MARSHALL WACE, LLP: 48,573
0.24% of Telix Pharmaceuticals Limited stock is owned by institutional investors.
Institutional investors have bought a total of 823.17 K shares in the last 24 months. This purchase volume represents approximately $8.05 M in transactions.